Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Manifestations of Systemic Sclerosis: Toward the Identification of New Prognostic Markers

NCT02371005 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT02371005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Manifestations of Systemic Sclerosis: Toward the Identification of New Prognostic Markers
Lead sponsor
University Hospital, Strasbourg, France
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2015
Completion date
June 30, 2021
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic